Fatigue
Also known as: Tiredness, Weariness
Methodology & AI Transparency ⓘ
Fatigue Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is fatigue? Fatigue is a feeling of weariness, tiredness, or lack of energy.
- 2 Real-world patient consensus: Synonyms for Fatigue (R53.83): Tiredness, Weariness (ADHD & Focus).
- 3 Typical cash cost range: Clinicians assessing Fatigue focus on prefrontal cortex catecholaminergic in Fatigue (R53.83: (dopamine D1) and targeted history.
- 4 Top reported side effects / signs: Key ADHD & Focus biomarkers for Fatigue (R53.83): Serum Ferritin & in Fatigue (R53.83: Iron Saturation) & ASRS-v1.1 / Vanderbilt in Fatigue (R53.83: Executive Score) (Functional symptom control (R53.83)).
Ask our AI Specialists anything about Fatigue
What Is Fatigue?
What is fatigue? Fatigue is a feeling of weariness, tiredness, or lack of energy. It can interfere with your usual daily activities. Fatigue can be a normal response to physical activity, emotional stress , boredom, or lack of sleep. But sometimes it can be a sign of a mental or physical condition. If you have been feeling tired for weeks, contact your health care provider. They can help you find out what's causing your fatigue and recommend ways to relieve it. What causes fatigue? Fatigue itself is not a disease; it's a symptom.
Pathophysiology, Underlying Causes & Clinical Presentation
Fatigue (R53.83) alters adhd & focus homeostasis through prefrontal cortex catecholaminergic in Fatigue (R53.83: (dopamine D1); Cross-referenced with NIH MeSH (Fatigue), clinical remission targets ASRS-v1.1 / Vanderbilt in Fatigue (R53.83: Executive Score) within Functional symptom control (R53.83).
Common Symptoms & Clinical Signs
- • Untreated pain and diseases like fibromyalgia
- • Parkinson's disease
- • Presentation of Fatigue (R53.83): difficulty sustaining focus in Fatigue (R53.83: on sequential or)
- • Secondary Fatigue clinical sign: time blindness, working-memory in Fatigue (R53.83: slips, and chronic)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Fatigue Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R53.83 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | ADHD, Autism & Behavioral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Ferritin & in Fatigue (R53.83: Iron Saturation) | Ferritin 50 – 120 ng/mL (R53.83) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: ASRS-v1.1 / Vanderbilt in Fatigue (R53.83: Executive Score) | Functional symptom control (R53.83) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Blood Pressure in Fatigue (R53.83: & Pulse (on) | < 125/80 mmHg; HR < 85 bpm (R53.83) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Fatigue
Treatment selection for Fatigue depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Fatigue)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Interventions for trouble sleeping in cancer patients and survivors-a: What a 6,528-Participant Study Found CBT-I is supported as a first-line treatment for trouble sleeping in cancer survivors, with significant benefits observed across sleep and non-sleep outcomes. JNCI cancer spectrum • 2024-04-30 • Meta-Analysis | N = 6,528 | 94/100 | PMID 38781520 ↗ |
| Managing Long COVID: Can Integrated care pathway Make a Real Difference? (What a 1,152-Person Study Found) Large, multi-site trials of optimal ICP interventions are feasible, but further trials are required. Nature medicine • 2026-08-15 • Phase III Randomized Trial | N = 1,152 | 90/100 | PMID 42521821 ↗ |
| Can This Approach Help? Inside the Latest Research on Dexamethasone for 12 weeks for reducing fatigue in patients receiving palliative Dexamethasone did not significantly reduce cancer-associated fatigue or improve QOL in patients receiving palliative chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer • 2025-07-31 • Phase III Randomized Trial | N = 126 | 88/100 | PMID 40739403 ↗ |
| Can This Approach Help? Inside the Latest Research on Testosterone and resistance training improved physical performance and reduced Fifty-two weeks of testosterone supplementation combined with progressive resistance training may enhance physical performance, alleviate fatigue, and had no notable detrimental impacts among males aged ≥70 suffering from... The aging male : the official journal of the International Society for the Study of the Aging Male • 2024-12-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 39289825 ↗ |
| Can This Approach Help? Inside the Latest Research on Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea-hypopnea index with a 4% desaturation criterion (primary outcome) was reduced from a median (IQR) of 20.5 (12.3-27.2) to 10.8 (5.6-18.5) in the AD109 2.5/75 mg arm (-47.1%), from 19.4 (13.7-26.4) to 9.5 (6.1-19.3) in the... American journal of respiratory and critical care medicine • 2023-12-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 37812772 ↗ |
Fatigue Patient Community & “People Like Me” Threads
Filter Fatigue community threads and patient logs by age, biological sex, dosage, and treatment duration.